Release Date: 29/04/11 13:23 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 383.62KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%